Patients may require life-long monitoring and a collaborative engagement with subspecialists to keep well in the long -term,” ...

Groundbreaking personalized kidney cancer vaccines show promise in early clinical trials, triggering strong immune responses ...

After their advanced kidney tumors were surgically removed, nine patients were protected from the cancer returning thanks to ...

Intravenous Opdivo, with $2.48 billion in sales, topped the list of precision oncology products in BMS's growth portfolio.